CN103417745A - Chinese herbal preparation for treating acute cholecystitis and preparation method thereof - Google Patents
Chinese herbal preparation for treating acute cholecystitis and preparation method thereof Download PDFInfo
- Publication number
- CN103417745A CN103417745A CN2013103495001A CN201310349500A CN103417745A CN 103417745 A CN103417745 A CN 103417745A CN 2013103495001 A CN2013103495001 A CN 2013103495001A CN 201310349500 A CN201310349500 A CN 201310349500A CN 103417745 A CN103417745 A CN 103417745A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- medicine preparation
- obtains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 69
- 201000001352 cholecystitis Diseases 0.000 title claims abstract description 32
- 208000000197 Acute Cholecystitis Diseases 0.000 title claims abstract description 17
- 206010008614 Cholecystitis acute Diseases 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 59
- 239000000463 material Substances 0.000 claims abstract description 24
- 241000746375 Andrographis Species 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 50
- 239000002245 particle Substances 0.000 claims description 40
- 239000011812 mixed powder Substances 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 32
- 244000025254 Cannabis sativa Species 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 238000011282 treatment Methods 0.000 claims description 18
- 244000221226 Armillaria mellea Species 0.000 claims description 15
- STECJAGHUSJQJN-USLFZFAMSA-N LSM-4015 Chemical compound C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-USLFZFAMSA-N 0.000 claims description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- 241000282994 Cervidae Species 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 230000001476 alcoholic effect Effects 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 10
- 239000002105 nanoparticle Substances 0.000 claims description 10
- 238000005325 percolation Methods 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 241000464908 Elliptica Species 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 238000005262 decarbonization Methods 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 239000012982 microporous membrane Substances 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008215 water for injection Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 13
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 abstract 1
- 241000216674 Armillaria tabescens Species 0.000 abstract 1
- 241001635617 Canscora Species 0.000 abstract 1
- 241001579122 Clinacanthus Species 0.000 abstract 1
- 241000717662 Clinopodium chinense Species 0.000 abstract 1
- 241000175995 Dichondra Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241001183967 Isodon Species 0.000 abstract 1
- 241001620257 Nauclea officinalis Species 0.000 abstract 1
- 240000005992 Physalis angulata Species 0.000 abstract 1
- 235000015857 Physalis angulata Nutrition 0.000 abstract 1
- 241000691155 Pteris multifida Species 0.000 abstract 1
- 241000410330 Schnabelia oligophylla Species 0.000 abstract 1
- 241000195974 Selaginella Species 0.000 abstract 1
- 235000002634 Solanum Nutrition 0.000 abstract 1
- 241000207763 Solanum Species 0.000 abstract 1
- 240000008104 Stachytarpheta jamaicensis Species 0.000 abstract 1
- 235000019032 Stachytarpheta jamaicensis Nutrition 0.000 abstract 1
- 241001530209 Swertia Species 0.000 abstract 1
- 241000317854 Uncinata Species 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 22
- 230000036407 pain Effects 0.000 description 22
- 230000001737 promoting effect Effects 0.000 description 17
- 231100000614 poison Toxicity 0.000 description 15
- 210000000232 gallbladder Anatomy 0.000 description 14
- 239000003440 toxic substance Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000008961 swelling Effects 0.000 description 12
- 208000001848 dysentery Diseases 0.000 description 11
- 208000006454 hepatitis Diseases 0.000 description 11
- 206010017553 Furuncle Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 206010000087 Abdominal pain upper Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 206010023126 Jaundice Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 208000004396 mastitis Diseases 0.000 description 7
- 231100000283 hepatitis Toxicity 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010010741 Conjunctivitis Diseases 0.000 description 5
- 208000004232 Enteritis Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 201000004484 acute conjunctivitis Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 210000003026 hypopharynx Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 208000019206 urinary tract infection Diseases 0.000 description 4
- 231100000611 venom Toxicity 0.000 description 4
- 239000002435 venom Substances 0.000 description 4
- 210000001048 venom Anatomy 0.000 description 4
- 208000005577 Gastroenteritis Diseases 0.000 description 3
- 206010067868 Skin mass Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 201000008383 nephritis Diseases 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010015137 Eructation Diseases 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000354 acute hepatitis Toxicity 0.000 description 2
- 208000027687 belching Diseases 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012435 Dermatitis and eczema Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010062693 Gallbladder enlargement Diseases 0.000 description 1
- 208000037768 Gallbladder perforation Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000012876 acute enteritis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000013110 gastrectomy Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940041007 third-generation cephalosporins Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a Chinese harbal preparation for treating acute cholecystitis and a preparation method thereof. The Chinese herbal preparation comprises the following raw materials: common andrographis herb, armillaria tabescens, linearstripe rabdosia herb, Schnabelia Oligophylla, Chinese brake herb, creeping dichondra herb, Nauclea officinalis, Clinopodium chinense, jamaica vervain, Solanum Vine, uncinata spikemoss herb, Physalis angulata, gardenia jasminoides ellis root, Swertia, nodding clinacanthus and Canscora melastomacea. The invention has the benefits that the Chinese harbal preparation provided by the invention utilizes the traditional Chinese medicine principle to clear away heat and toxic materials and soothe liver-gallbladder and has the advantages of definite curative effect, high efficiency, high effective rate and less side effects.
Description
Technical field
The present invention relates to pharmaceutical technology, particularly a kind of Chinese medicine preparation for the treatment of acute cholecystitis and preparation method thereof.
Background technology
Cholecystitis is with the pain over the hypochondriac region and take on to the right the back radiation, nausea and vomiting, and under appetite, degradation is main clinical manifestation.Because of antibacterial or other factors infection, cause gallbladder wall and neck of gallbladder congestion and edema for gallbladder, even stick together with surrounding tissue, bile excretion is obstructed, and neck of gallbladder and cystic duct shrink simultaneously, makes bile concentrated, be difficult for discharging, cause the antibacterial amount reproduction, increase the weight of the gallbladder inflammation.
Acute cholecystitis is a kind of in cholecystitis, and it is commonly encountered diseases, frequently-occurring disease clinically, often merges cholelithiasis.Clinical symptoms shows as heating, upper right abdomen pain and tenderness, pain often is radiated to shoulder, scapular region and back, the performances such as the companion feels sick, vomiting, slight jaundice and leukocyte counts increase, often because cystic duct blocks, chemical irritation and antibacterial infect caused acute cholecystitis disease sexually transmitted disease (STD) and become.
Acute cholecystitis belongs to the sick categories such as Chinese medicine " gallbladder-distention " " hypochondriac pain " " stomachache " " jaundice ", the many and eating and drinking without temperance of its cause of disease, and disorder of emotion, the factors such as overstrain are relevant.The thick greasy or unclean thing of surfeit delicious food and hungry full immoderate, long-pending humidifying expectorant heat-dissipating of a specified duration is stopped up and is held back middle Jiao, so that liver and gall lose in catharsis, thereby gastral cavity side of body feeling of distension and oppression pain, nausea and vomiting; Or disorder of emotion, be worried angry, the liver and gall dysfunction of acting as a pivot, bile is logical fall not smooth, stagnated QI transforming into fire, venation is become estranged, and satisfies into hypochondriac pain, gallbladder-distention.
Summary of the invention
Technical problem to be solved by this invention is, a kind of Chinese medicine preparation for the treatment of acute cholecystitis and preparation method thereof is provided, the Chinese medicine preparation heat-clearing and toxic substances removing, and depressed liver-energy dispersing and function of gallbladder promoting, determined curative effect, side effect is little
In order to solve the problems of the technologies described above, the invention provides a kind of Chinese medicine preparation for the treatment of acute cholecystitis, wherein, described Chinese medicine preparation comprises following raw medicinal material: Herba Andrographis, Armillaria mella tabescens (Scop.ex Fr.) Sing., Herba Rabdosiae Lophanthoidis, Radix haleniae ellipticae, Herba Pteridis Multifidae, Herba Dichodrae, Lignum et Radix Naucleae, Herba Clinopodii Polycephali, Herba Stachytarphetae Jamaicensis, Herba Solani Lyrati, CUIYUNCAO, lantern bubble, Radix Fructus Gardeniae, Zhang Yacao, Herba Clinacanthi Nutantis and Luo Xingcao.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material can be preferably as follows: 30～40 parts of Herba Andrographis, 25～35 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 20～30 parts of Herba Rabdosiae Lophanthoidiss, 10～20 parts of Radix haleniae ellipticaes, 15～25 parts of Herba Pteridis Multifidaes, 20～30 parts of Herba Dichodraees, 10～20 parts of Lignum et Radix Naucleae, 20～30 parts of Herba Clinopodii Polycephalis, 10～20 parts of Herba Stachytarphetae Jamaicensiss, 15～30 parts of Herba Solani Lyratis, 10～20 parts of CUIYUNCAO, 15～30 parts of lantern bubbles, 10～20 parts of Radix Fructus Gardeniae, 10～20 parts of river deer tooth grass, 15～25 parts of 8～16 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material can also be preferably as follows: 30～35 parts of Herba Andrographis, 30～35 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 20～25 parts of Herba Rabdosiae Lophanthoidiss, 10～15 parts of Radix haleniae ellipticaes, 20～25 parts of Herba Pteridis Multifidaes, 25～30 parts of Herba Dichodraees, 15～20 parts of Lignum et Radix Naucleae, 20～25 parts of Herba Clinopodii Polycephalis, 10～15 parts of Herba Stachytarphetae Jamaicensiss, 15～25 parts of Herba Solani Lyratis, 10～15 parts of CUIYUNCAO, 15～25 parts of lantern bubbles, 10～15 parts of Radix Fructus Gardeniae, 15～20 parts of river deer tooth grass, 15～20 parts of 10～16 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material can be preferably as follows again: 33 parts of Herba Andrographis, 31 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 22 parts of Herba Rabdosiae Lophanthoidiss, 13 parts of Radix haleniae ellipticaes, 24 parts of Herba Pteridis Multifidaes, 27 parts of Herba Dichodraees, 15 parts of Lignum et Radix Naucleae, 22 parts of Herba Clinopodii Polycephalis, 14 parts of Herba Stachytarphetae Jamaicensiss, 23 parts of Herba Solani Lyratis, 11 parts of CUIYUNCAO, 17 parts of lantern bubbles, 13 parts of Radix Fructus Gardeniae, 16 parts of river deer tooth grass, 18 parts of 12 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
Wherein, when the dosage form of described Chinese medicine preparation is tablet, its preparation method comprises the following steps:
The first step: each raw medicinal material of described Chinese medicine preparation is mixed in proportion, adds the ethanol that the determining alcohol with respect to 5～8 times of mixture qualities is 75%～80%, reflux 4～6 hours, extract, and filters and obtain the first extracting solution; The medicinal residues that filter to obtain add the ethanol that the determining alcohol with respect to 3～5 times of medicinal residues quality is 70%～80% again, and reflux 120～180 minutes, extract, and filters and obtain the second extracting solution; The first extracting solution and the second extracting solution are merged, and concentrating under reduced pressure is removed alcohol solvent, and drying obtains and gets dry extract;
Second step: the dry cream that the first step is obtained is placed in super micron mill pulverizes 180～220 minutes, pulverizes and sieves and obtains 200～400 purpose micropowders;
The 3rd step: in the micropowders obtained at second step, add the microcrystalline Cellulose with respect to 0.25～0.45 times of its quality, the lactose of 0.25～0.4 times and the starch of 0.2～0.3 times, sieve, mix homogeneously, granulate, drying, add the magnesium stearate with respect to 0.03～0.05 times of micropowders quality, granulate, tabletting, make.
Wherein, when the dosage form of described Chinese medicine preparation is injectable powder, its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into the mixed powder that super micron mill is ground into the micron particles of 0.1～10 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 90%;
Second step, add the ethanol that the determining alcohol with respect to 4～6 times of the quality of described mixed powder is 90%～95% in the mixed powder that the first step obtains, stirring and dissolving obtains alcoholic solution, by alcoholic solution under the condition of 5 ℃～8 ℃ standing 50～80 hours, adopt percolation with the speed of 1～2ml per minute percolation slowly, collect percolate, concentrated and dry, and again put into super micron mill and pulverize 150～180 minutes, obtain the mixed powder of the micron particles of 0.1～10 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
The 3rd step, get mixed powder 100g～200g that second step obtains, and adds propylene glycol 350g～550g, add 4000ml water for injection, stir and make its dissolving, further inject water to 10000ml, add again 20g～40g needle-use activated carbon, fully stir 100～150 minutes; Decarbonization filtering; With 0.22～0.24 μ m filtering with microporous membrane; Lyophilization obtains sterilized powder, the packing embedding.
Beneficial effect of the present invention: Chinese medicine preparation provided by the invention utilizes the traditional theory of Chinese medical science of China, heat-clearing and toxic substances removing, and depressed liver-energy dispersing and function of gallbladder promoting, have determined curative effect, instant effect, effective percentage is high, the advantage that side effect is little.
The specific embodiment
The specific embodiment of the invention provides a kind of Chinese medicine preparation for the treatment of acute cholecystitis, and wherein, described Chinese medicine preparation comprises following raw medicinal material: Herba Andrographis, Armillaria mella tabescens (Scop.ex Fr.) Sing., Herba Rabdosiae Lophanthoidis, Radix haleniae ellipticae, Herba Pteridis Multifidae, Herba Dichodrae, Lignum et Radix Naucleae, Herba Clinopodii Polycephali, Herba Stachytarphetae Jamaicensis, Herba Solani Lyrati, CUIYUNCAO, lantern bubble, Radix Fructus Gardeniae, river deer tooth grass, Herba Clinacanthi Nutantis and Luo Xingcao.
In described Chinese medicine preparation, the pharmacology of each raw medicinal material is as follows:
Herba Andrographis: bitter in the mouth, cold in nature.GUIXIN, lung, large intestine, urinary bladder channel.Heat-clearing and toxic substances removing, the removing heat from blood detumescence.Control acute bacillary dysentery, gastroenteritis, flu, epidemic encephalitis, tracheitis, pneumonia, pertussis, pulmonary tuberculosis, lung abscess, cholecystitis, hypertension, epistaxis, oropharynx swells and ache, furuncle carbuncle, burn due to hot liquid or fire, venom." Jiangxi medical herbs ": clearing away heat and cooling blood, reducing swelling and alleviating pain, control cholecystitis, bronchitis, hypertension, pertussis.
Armillaria mella tabescens (Scop.ex Fr.) Sing.: cold in nature, bitter in the mouth.Heat-clearing and toxic substances removing.Main acute and chronic cholecystitis, biliary tract infection, hepatitis, appendicitis, otitis media.
Herba Rabdosiae Lophanthoidis: hardship, cold.Clearing away heat-damp and promoting diuresis, cool the blood dissipate blood stasis.Control acute hepatitis, acute cholecystitis, dysentery, enteritis, the difficulty in urination, traumatic injury congestive edema.Guangzhou army " Chinese herbal medicine handbook commonly used: heat clearing away, dampness removing, jaundice eliminating.Control acute icterohepatitis, acute cholecystitis.
Radix haleniae ellipticae: hardship, cold.Clearing away heat-damp and promoting diuresis, the suppressing the hyperactive liver function of gallbladder promoting.For acute icterohepatitis, cholecystitis, gastritis, dizziness headache, toothache.
Herba Pteridis Multifidae: light, micro-hardship, cool.Clearing away heat-damp and promoting diuresis, removing toxic substances dysentery relieving, cooling blood for hemostasis.For dysentery, gastroenteritis, hepatitis, urinary system infection, cat fever, laryngopharynx swelling and pain, leucorrhea, metrorrhagia, pesticide intoxication; Traumatic hemorrhage is controlled in external, burn and scald." classification medical herbs ": control all pyretic toxicity, detumescence, relieve inflammation or internal heat.Control the carbuncle skin ulcer, acute mastitis, stranguria.
Herba Dichodrae: hardship, suffering, cool.Return lung, Liver Channel.Heat clearing away, dampness removing, removing toxic substances.The subcutaneous ulcer of harnessing the Yellow River, dysentery, sand Stranguria, nebulousurine, edema, furuncle swelling toxin, traumatic injury, venom." Chinese Plants will ": all herbal medicine has the merit of clearing away heat and promoting diuresis, wind-expelling pain-stopping, hemostasia and promoting granulation, eliminating inflammation and expelling toxin, parasite killing.But treating acute and chronic hepatitis, icterohepatitis, cholecystitis, nephritis, urinary system infection, tonsillitis, stomatitis and carbuncle furuncle are treated poison, venom, acute mastitis, dysentery, malaria, pneumorrhagia etc.
Lignum et Radix Naucleae: hardship, cold.Heat-clearing and toxic substances removing, reducing swelling and alleviating pain.Treating acute tonsillitis, pharyngolaryngitis, mastitis, enteritis, bacillary dysentery, urinary tract infection, cholecystitis, ulcer of the lower limb, tinea pedis infects, furuncle and phyma pus infections, dermatitis and eczema.
Herba Clinopodii Polycephali: acrid in the mouth, hardship, cool in nature.Wind and heat dispersing, removing toxic substances and promoting subsidence of swelling, hemostasis.Main cold, fever, heatstroke, laryngopharynx swelling and pain, diphtheria, acute cholecystitis, hepatitis, enteritis, dysentery, mastitis, furuncle swelling toxin, allergic dermatitis, acute conjunctivitis, hematuria, metrorrhagia, gingival hemorrhage, traumatic hemorrhage.Guangzhou air force " Chinese herbal medicine handbook commonly used: clearing away heat-fire, promoting blood circulation and detumescence.Control acute cholecystitis, hepatitis, dysentery, parotitis, enteritis, hematuria, acute conjunctivitis, venom, innominate toxic swelling, mastitis, knife injury.
Herba Stachytarphetae Jamaicensis: sweet in the mouth, micro-hardship, cold in nature.GUIXIN, liver, kidney channel.Clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling.Main pyretic stranguria, stranguria caused by urinary stone, nebulousurine, leucorrhea, rheumatic ostalgia, acute conjunctivitis, pharyngolaryngitis, gingivitis, cholecystitis, carbuncle furuncle, hemorrhoid, treating swelling and pain by traumatic injury.Guangzhou army " Chinese herbal medicine handbook commonly used: heat-clearing and toxic substances removing, relieving stranguria by diuresis.Control lithangiuria, urinary tract infection, bones and muscles pain due to rheumatism, laryngitis, acute conjunctivitis, carbuncle furuncle and phyma pain.
Herba Solani Lyrati: sweet, hardship, cold.Heat clearing away, dampness removing, dispel the wind, removing toxic substances.The treating malaria disease, jaundice, edema, gonorrhea, rheumatic arthritis, erysipelas, furuncle.
CUIYUNCAO: sweet, light, cool.Heat-clearing and toxic substances removing, dampness removing dredging collateral, hemostasia and promoting granulation, preventing phlegm from forming and stopping coughing.For icterohepatitis, dysentery, hyperpyrexia convulsion, cholecystitis, nephritis, enteritis, spit blood, has blood in stool, rheumatic arthritis.Urticaria is controlled in external, acute mastitis, traumatic hemorrhage and burn and scald.
The lantern bubble: hardship, cool.Clearing away heat-damp and promoting diuresis, expelling phlegm for arresting cough, hard masses softening and resolving.For icterohepatitis, cholecystitis, cold, fever, laryngopharynx swelling and pain, bronchitis, lung abscess, parotitis, orchitis, cystitis, hematuria, the tuberculosis of cervical lymph nodes; Impetigo is controlled in external, eczema, furuncle and phyma.
Radix Fructus Gardeniae: sweet, hardship, cold.Return liver, gallbladder, stomach warp.Clearing away heat-damp and promoting diuresis, cooling blood for hemostasis.Main icterohepatitis, dysentery, cholecystitis, the high heat of flu, spit blood, epistaxis, urinary tract infection, oedema due to nephritis, mastitis, acute toothache, sore and toxic, traumatic injury.
River deer tooth grass: hardship, suffering, cool.Heat-clearing and toxic substances removing, dampness removing, depressed liver-energy dispersing and function of gallbladder promoting.Cure mainly acute hepatitis, chronic hepatitis, cholecystitis, cold, fever, laryngopharynx swelling and pain, gingival swelling and pain, urinary tract infection, gastroenteritis, dysentery, acute catarrhal conjunctivitis.
Herba Clinacanthi Nutantis: sweet, flat.Enter liver, spleen, kidney channel.The liver heat removing function of gallbladder promoting, the regulating menstruation blood stasis dispelling." the Guangxi medicine is planted register ": regulating menstruation, blood stasis removing, detumescence, pain relieving.Control injury and bone fracture, anemia, jaundice, rheumatism." Chinese herbal medicine ": the liver heat removing choleretic effect is arranged, treatment jaundice and hepatitis ascites.
Luo Xingcao: hardship, cold.Heat-clearing and toxic substances removing, eliminating stasis to stop pain.Cure mainly hepatitis, cholecystitis, acute enteritis, dysentery, tonsillitis, injury and bone fracture, arthralgia.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material can be preferably as follows: 30～40 parts of Herba Andrographis, 25～35 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 20～30 parts of Herba Rabdosiae Lophanthoidiss, 10～20 parts of Radix haleniae ellipticaes, 15～25 parts of Herba Pteridis Multifidaes, 20～30 parts of Herba Dichodraees, 10～20 parts of Lignum et Radix Naucleae, 20～30 parts of Herba Clinopodii Polycephalis, 10～20 parts of Herba Stachytarphetae Jamaicensiss, 15～30 parts of Herba Solani Lyratis, 10～20 parts of CUIYUNCAO, 15～30 parts of lantern bubbles, 10～20 parts of Radix Fructus Gardeniae, 10～20 parts of river deer tooth grass, 15～25 parts of 8～16 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material can also be preferably as follows: 30～35 parts of Herba Andrographis, 30～35 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 20～25 parts of Herba Rabdosiae Lophanthoidiss, 10～15 parts of Radix haleniae ellipticaes, 20～25 parts of Herba Pteridis Multifidaes, 25～30 parts of Herba Dichodraees, 15～20 parts of Lignum et Radix Naucleae, 20～25 parts of Herba Clinopodii Polycephalis, 10～15 parts of Herba Stachytarphetae Jamaicensiss, 15～25 parts of Herba Solani Lyratis, 10～15 parts of CUIYUNCAO, 15～25 parts of lantern bubbles, 10～15 parts of Radix Fructus Gardeniae, 15～20 parts of river deer tooth grass, 15～20 parts of 10～16 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material can be preferably as follows again: 33 parts of Herba Andrographis, 31 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 22 parts of Herba Rabdosiae Lophanthoidiss, 13 parts of Radix haleniae ellipticaes, 24 parts of Herba Pteridis Multifidaes, 27 parts of Herba Dichodraees, 15 parts of Lignum et Radix Naucleae, 22 parts of Herba Clinopodii Polycephalis, 14 parts of Herba Stachytarphetae Jamaicensiss, 23 parts of Herba Solani Lyratis, 11 parts of CUIYUNCAO, 17 parts of lantern bubbles, 13 parts of Radix Fructus Gardeniae, 16 parts of river deer tooth grass, 18 parts of 12 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
Wherein, when the dosage form of described Chinese medicine preparation is tablet, its preparation method comprises the following steps:
The first step: each raw medicinal material of described Chinese medicine preparation is mixed in proportion, adds the ethanol that the determining alcohol with respect to 5～8 times of mixture qualities is 75%～80%, reflux 4～6 hours, extract, and filters and obtain the first extracting solution; The medicinal residues that filter to obtain add the ethanol that the determining alcohol with respect to 3～5 times of medicinal residues quality is 70%～80% again, and reflux 120～180 minutes, extract, and filters and obtain the second extracting solution; The first extracting solution and the second extracting solution are merged, and concentrating under reduced pressure is removed alcohol solvent, and drying obtains and gets dry extract;
Second step: the dry cream that the first step is obtained is placed in super micron mill pulverizes 180～220 minutes, pulverizes and sieves and obtains 200～400 purpose micropowders;
The 3rd step: in the micropowders obtained at second step, add the microcrystalline Cellulose with respect to 0.25～0.45 times of its quality, the lactose of 0.25～0.4 times and the starch of 0.2～0.3 times, sieve, mix homogeneously, granulate, drying, add the magnesium stearate with respect to 0.03～0.05 times of micropowders quality, granulate, tabletting, make.
Wherein, when the dosage form of described Chinese medicine preparation is injectable powder, its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into the mixed powder that super micron mill is ground into the micron particles of 0.1～10 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 90%;
Second step, add the ethanol that the determining alcohol with respect to 4～6 times of the quality of described mixed powder is 90%～95% in the mixed powder that the first step obtains, stirring and dissolving obtains alcoholic solution, by alcoholic solution under the condition of 5 ℃～8 ℃ standing 50～80 hours, adopt percolation with the speed of 1～2ml per minute percolation slowly, collect percolate, concentrated and dry, and again put into super micron mill and pulverize 150～180 minutes, obtain the mixed powder of the micron particles of 0.1～10 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
The 3rd step, get mixed powder 100g～200g that second step obtains, and adds propylene glycol 350g～550g, add 4000ml water for injection, stir and make its dissolving, further inject water to 10000ml, add again 20g～40g needle-use activated carbon, fully stir 100～150 minutes; Decarbonization filtering; With 0.22～0.24 μ m filtering with microporous membrane; Lyophilization obtains sterilized powder, the packing embedding.
Below adopt example to describe embodiments of the present invention in detail, to the present invention, how the application technology means solve technical problem whereby, and the implementation procedure of reaching technique effect can fully understand and implement according to this.
Tablet prepared by embodiment 1 the present invention
Get Herba Andrographis 330g, Armillaria mella tabescens (Scop.ex Fr.) Sing. 310g, Herba Rabdosiae Lophanthoidis 220g, Radix haleniae ellipticae 130g, Herba Pteridis Multifidae 240g, Herba Dichodrae 270g, Lignum et Radix Naucleae 150g, Herba Clinopodii Polycephali 220g, Herba Stachytarphetae Jamaicensis 140g, Herba Solani Lyrati 230g, CUIYUNCAO 110g, lantern bubble 170g, Radix Fructus Gardeniae 130g, river deer tooth grass 160g, Herba Clinacanthi Nutantis 120g and Luo Xing grass 180g.
Its preparation method comprises the following steps:
The first step: each raw medicinal material is mixed in proportion, adds the ethanol that the determining alcohol with respect to 7 times of mixture qualities is 80%, reflux 6 hours, extract, and filters and obtain the first extracting solution; The medicinal residues that filter to obtain add the ethanol that the determining alcohol with respect to 4 times of medicinal residues quality is 75% again, and reflux 150 minutes, extract, and filters and obtain the second extracting solution; The first extracting solution and the second extracting solution are merged, and concentrating under reduced pressure is removed alcohol solvent, and drying obtains and gets dry extract;
Second step: the dry cream that the first step is obtained is placed in super micron mill and pulverizes 200 minutes, pulverizes and sieves and obtains 400 purpose micropowders;
The 3rd step: add the microcrystalline Cellulose with respect to 0.35 times of its quality, the lactose of 0.3 times and the starch of 0.25 times in the micropowders obtained at second step, sieve, mix homogeneously, granulate, drying, add the magnesium stearate with respect to 0.03 times of micropowders quality, granulate, tabletting, make.
Injectable powder prepared by embodiment 2 the present invention
Get Herba Andrographis 310g, Armillaria mella tabescens (Scop.ex Fr.) Sing. 340g, Herba Rabdosiae Lophanthoidis 240g, Radix haleniae ellipticae 110g, Herba Pteridis Multifidae 220g, Herba Dichodrae 290g, Lignum et Radix Naucleae 180g, Herba Clinopodii Polycephali 230g, Herba Stachytarphetae Jamaicensis 120g, Herba Solani Lyrati 190g, CUIYUNCAO 130g, lantern bubble 210g, Radix Fructus Gardeniae 110g, river deer tooth grass 180g, Herba Clinacanthi Nutantis 140g and Luo Xing grass 160g;
Its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into the mixed powder that super micron mill is ground into the micron particles of 4 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 90%;
Second step, add the ethanol that the determining alcohol with respect to 5 times of the quality of described mixed powder is 95% in the mixed powder that the first step obtains, stirring and dissolving obtains alcoholic solution, by alcoholic solution under the condition of 8 ℃ standing 60 hours, adopt percolation with the speed of 1ml per minute percolation slowly, collect percolate, concentrated and dry, and again put into super micron mill and pulverize 170 minutes, obtain the mixed powder of the micron particles of 1 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
The 3rd step, get the mixed powder 180g that second step obtains, and adds propylene glycol 450g, adds 4000ml water for injection, stirs and make its dissolving, further injects water to 10000ml, then add the 30g needle-use activated carbon, fully stirs 130 minutes; Decarbonization filtering; With 0.22 μ m filtering with microporous membrane; Lyophilization obtains sterilized powder, the packing embedding.
Toxicity test:
Acute toxicity testing: 60 of application mices, male and female half and half, body weight 28～34g, carry out acute toxicity test.Mice is divided into two groups at random, be matched group and administration group, before experiment, fasting is 12 hours, and the Chinese medicinal tablet of embodiments of the invention 1 preparation is dissolved in water, (concentration is 8.34g crude drug/ml, maximum concentration) gavage, the gavage volume is 5ml/kg (being that single-dose dosage is 41.7 crude drugs/kg), matched group gives the equivalent normal saline, administration in one day 2 times, delivery time 6 hours, after administration, Continuous Observation is 14 days, and record mice toxic reaction and death toll.Experimental result shows: with matched group, compare, after administration, mice has no notable difference, experiment Continuous Observation 14 days, and mice overall health of patients, diet, drinking-water, body weight gain are all normal.Mice oral administration gavage tablet of the present invention is LD50>41.7 crude drugs/kg, and every day, maximum dosage-feeding was 83.4 crude drugs/kg/ day.Chinese medicine preparation clinical application amount of the present invention is 4.8g crude drug/day/people, becomes body weight for humans in 60KG, and average dosage is 0.04g crude drug/kg/ day.By weighing machine: the dosis tolerata of mice (average weight take 31g) oral administration gavage Chinese medicine preparation of the present invention is quantity 1042 times.Therefore Chinese medicine preparation acute toxicity of the present invention is extremely low, clinical drug safety.
Long term toxicity test: the tablet of embodiment 1 prepared by the present invention to 3 groups of rats by 15.45,22.68 and 43.12g crude drug/kg continuous use 15 weeks (1.0ml/100g body weight, every day 2 times) and drug withdrawal after 3 weeks, result shows: Chinese medicine preparation of the present invention all has no significant effect indexs such as the hair of rat, behavior, defecation, body weight, organ weights, hemogram, hepatic and renal function, blood glucose, blood fat, and the internal organs naked eyes do not find that difference changes; The histological examination result shows, medication 15 weeks and drug withdrawal are after 3 weeks, and each internal organs of rat are all without obviously changing.Illustrate that toxicity is little after Chinese medicine preparation of the present invention is to the rat long-term prescription, also there is no the difference reaction after drug withdrawal, application safety.
Clinical data:
Case is selected: select acute cholecystitis patient 160 examples in year April in May, 2009 to 2012, male's 82 examples wherein, women's 78 examples; 15～73 years old age, average (34 ± 8) year; Stomachache, heating are all arranged, stomachache be positioned under right upper quadrant of the abdomen or xiphoid-process and with feeling sick, vomiter's 134 examples, 37.5～38.9 ℃ of person's 142 examples of body temperature; Jaundice person's 84 examples appear, neutrophilic leukocyte rising person 126 examples.Be divided into treatment group and each 80 examples of matched group by the table of random number method.The no significant differences (P>0.05) such as two groups of Genders, age, symptom, have comparability.
Diagnostic criteria: 1. symptom is formulated in reference " clinical disease diagnosis is according to curing the improvement standard ": upper right abdomen constant pain, and paroxysmal increases the weight of, and shoulder radiation to the right, and the companion feels sick, vomits and heating; 2. sign: upper right abdominal pressure pain, muscle tonus, Fei Shi does not levy the positive, sometimes can lay one's hand on and enlargement gallbladder that tool is touched a tender spot; 3. blood test: total white blood cells and neutrophil count significantly raise, and part has liver function change, serum total bilirubin slightly to increase; 4. ultrasound diagnosis: the gallbladder enlargement, cyst wall thickens, visible foreign matters ripple, light group, sound shadow.
Excluded cases standard: 1. the important organ dysfunction persons such as severe cardiac, liver, kidney are arranged; 2. gestation or women breast-feeding their children, allergic constitution person; 3. be associated with severe complication and be badly in need of the operative treatment person, as perforation of gallbladder, acute diffuse peritonitis or the pancreatitis of acute necrosis type etc.; 4. single calculus>0.5cm person is pointed out in ultrasound diagnosis; 5. ultrasound diagnosis prompting neck of gallbladder does not obviously block the person; 6. did the Subtotal gastrectomy art, especially Billra th II formula person.
Therapeutic Method: two groups of equal fasting, water (except medicine), with the serious vomiter arrangement gastrointestinal decompression of still needing, give suitable fluid infusion, correct water, electrolyte disturbance, maintain acid-base balance.The conventional antibacterials of using of matched group, take the 3rd generation cephalosporin and quinolones as main, add and use the spasmolysis and analgesia medicine depending on the state of an illness.Treatment group adopts the tablet of the embodiment of the present invention 1 preparation.Every day 3 times, each 3.
Observation item: the observation patient suffers from abdominal pain and disappears and abdominal distention remission time and other clinical symptoms and sign.
In curative effect judging standard: clinical cure: 3d, symptom, sign are alleviated; In 7d, symptom, sign disappear, and the lab testing indices is all normal.Symptom, sign significantly alleviate in produce effects: 7d, and every laboratory is an a little higher than normal value normally or only.Effectively: in 7d, symptom, sign alleviate, and every lab testing is significantly improved.Invalid: in 7d, symptom, sign have no obvious improvement, even worsen or change hands art and treat.
Therapeutic outcome: two groups of Clinical efficacy comparisons are in Table 1.Result: the treatment group curative effect is better than matched group (P<0.05).
Table 1 liang group Clinical efficacy comparison
| Group | n | Clinical cure | Produce effects | Effectively | Invalid | Total effective rate |
| Treatment group | 80 | 62 | 8 | 8 | 2 | 78(97.5％) * |
| Matched group | 80 | 38 | 12 | 22 | 8 | 72(90％) |
With matched group, compare,
*P<0.05.
Two groups of stomachache disappear and the abdominal distention remission time relatively in Table 2.Result: treatment group all is shorter than matched group (P<0.01).
Table 2 liang group stomachache disappears and the abdominal distention remission time compares
| Group | n | The stomachache extinction time | The abdominal distention remission time |
| Treatment group | 80 | 49±11 ** | 43±12 ** |
| Matched group | 80 | 71±16 | 90±25 |
With matched group, compare,
*P<0.01.
Body temperature before and after two groups of treatments, numeration of leukocyte relatively, the results are shown in Table 3.
Body temperature before and after table 3 liang group treatment, numeration of leukocyte relatively
Be showed no untoward reaction in two groups of patient treatment processes and occur, before and after treatment, hematuria routine and electrolyte balance, hepatic and renal function inspection, electrocardiogram are not all found obviously abnormal.
Concrete case: Zheng, the female, 40 years old, upper right abdomen pain 2 days, took antibiotic medicine without alleviation.The upper right angina abdominis, and take on the back radiation to the right, belching and acid regurgitation, bitter taste is vexed, defecates not well.38.4 ℃ of the temperature of having a medical check-up, spirit is withered, and abdominal pressure pain in upper right is obvious, the murphy sign positive, red tongue yellow and greasy fur, stringy and rolling pulse.B ultrasonic prompting gallbladder 6.4cm * 4.6cm, wall thickness 0.6cm, crude.Be diagnosed as acute cholecystitis.Take the tablet of the embodiment of the present invention 1 preparation, every day 3 times, each 3, treat 4 days rear right Upper abdominal paines and obviously alleviate, without belching and acid regurgitation, stomach receive can, two just adjust.7 days rear right Upper abdominal paines disappear, without the shoulder back pain, stomach receive can, two just adjust, the white and thin fur soft pulse.B ultrasonic prompting gallbladder 5cm * 3cm, wall thickness 0.3cm is smooth.Recovery from illness.Follow up a case by regular visits to not recurrence in 1 year.
The above, be only preferred embodiment of the present invention, is not the present invention to be done to the restriction of other form, and any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the equivalent embodiment of equivalent variations.But every technical solution of the present invention content that do not break away from, any simple modification, equivalent variations and the remodeling above embodiment done according to technical spirit of the present invention, still belong to the protection domain of technical solution of the present invention.
Claims (8)
1. a Chinese medicine preparation for the treatment of acute cholecystitis, is characterized in that, described Chinese medicine preparation comprises following raw medicinal material: Herba Andrographis, Armillaria mella tabescens (Scop.ex Fr.) Sing., Herba Rabdosiae Lophanthoidis, Radix haleniae ellipticae, Herba Pteridis Multifidae, Herba Dichodrae, Lignum et Radix Naucleae, Herba Clinopodii Polycephali, Herba Stachytarphetae Jamaicensis, Herba Solani Lyrati, CUIYUNCAO, lantern bubble, Radix Fructus Gardeniae, river deer tooth grass, Herba Clinacanthi Nutantis and Luo Xingcao.
2. Chinese medicine preparation as claimed in claim 1, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is as follows: 30～40 parts of Herba Andrographis, 25～35 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 20～30 parts of Herba Rabdosiae Lophanthoidiss, 10～20 parts of Radix haleniae ellipticaes, 15～25 parts of Herba Pteridis Multifidaes, 20～30 parts of Herba Dichodraees, 10～20 parts of Lignum et Radix Naucleae, 20～30 parts of Herba Clinopodii Polycephalis, 10～20 parts of Herba Stachytarphetae Jamaicensiss, 15～30 parts of Herba Solani Lyratis, 10～20 parts of CUIYUNCAO, 15～30 parts of lantern bubbles, 10～20 parts of Radix Fructus Gardeniae, 10～20 parts of river deer tooth grass, 15～25 parts of 8～16 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
3. Chinese medicine preparation as claimed in claim 1 or 2, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is as follows: 30～35 parts of Herba Andrographis, 30～35 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 20～25 parts of Herba Rabdosiae Lophanthoidiss, 10～15 parts of Radix haleniae ellipticaes, 20～25 parts of Herba Pteridis Multifidaes, 25～30 parts of Herba Dichodraees, 15～20 parts of Lignum et Radix Naucleae, 20～25 parts of Herba Clinopodii Polycephalis, 10～15 parts of Herba Stachytarphetae Jamaicensiss, 15～25 parts of Herba Solani Lyratis, 10～15 parts of CUIYUNCAO, 15～25 parts of lantern bubbles, 10～15 parts of Radix Fructus Gardeniae, 15～20 parts of river deer tooth grass, 15～20 parts of 10～16 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
4. Chinese medicine preparation as described as claims 1 to 3, is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is as follows: 33 parts of Herba Andrographis, 31 parts of Armillaria mella tabescens (Scop.ex Fr.) Sing.s, 22 parts of Herba Rabdosiae Lophanthoidiss, 13 parts of Radix haleniae ellipticaes, 24 parts of Herba Pteridis Multifidaes, 27 parts of Herba Dichodraees, 15 parts of Lignum et Radix Naucleae, 22 parts of Herba Clinopodii Polycephalis, 14 parts of Herba Stachytarphetae Jamaicensiss, 23 parts of Herba Solani Lyratis, 11 parts of CUIYUNCAO, 17 parts of lantern bubbles, 13 parts of Radix Fructus Gardeniae, 16 parts of river deer tooth grass, 18 parts of 12 parts of Herba Clinacanthi Nutantis and Luo Xing grass.
5. Chinese medicine preparation as described as claim 1 to 4, is characterized in that, when the dosage form of described Chinese medicine preparation is tablet, its preparation method comprises the following steps:
The first step: each raw medicinal material of described Chinese medicine preparation is mixed in proportion, adds the ethanol that the determining alcohol with respect to 5～8 times of mixture qualities is 75%～80%, reflux 4～6 hours, extract, and filters and obtain the first extracting solution; The medicinal residues that filter to obtain add the ethanol that the determining alcohol with respect to 3～5 times of medicinal residues quality is 70%～80% again, and reflux 120～180 minutes, extract, and filters and obtain the second extracting solution; The first extracting solution and the second extracting solution are merged, and concentrating under reduced pressure is removed alcohol solvent, and drying obtains and gets dry extract;
Second step: the dry cream that the first step is obtained is placed in super micron mill pulverizes 180～220 minutes, pulverizes and sieves and obtains 200～400 purpose micropowders;
The 3rd step: in the micropowders obtained at second step, add the microcrystalline Cellulose with respect to 0.25～0.45 times of its quality, the lactose of 0.25～0.4 times and the starch of 0.2～0.3 times, sieve, mix homogeneously, granulate, drying, add the magnesium stearate with respect to 0.03～0.05 times of micropowders quality, granulate, tabletting, make.
6. Chinese medicine preparation as described as claim 1 to 4, is characterized in that, when the dosage form of described Chinese medicine preparation is injectable powder, its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into the mixed powder that super micron mill is ground into the micron particles of 0.1～10 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 90%;
Second step, add the ethanol that the determining alcohol with respect to 4～6 times of the quality of described mixed powder is 90%～95% in the mixed powder that the first step obtains, stirring and dissolving obtains alcoholic solution, by alcoholic solution under the condition of 5 ℃～8 ℃ standing 50～80 hours, adopt percolation with the speed of 1～2ml per minute percolation slowly, collect percolate, concentrated and dry, and again put into super micron mill and pulverize 150～180 minutes, obtain the mixed powder of the micron particles of 0.1～10 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
The 3rd step, get mixed powder 100g～200g that second step obtains, and adds propylene glycol 350g～550g, add 4000ml water for injection, stir and make its dissolving, further inject water to 10000ml, add again 20g～40g needle-use activated carbon, fully stir 100～150 minutes; Decarbonization filtering; With 0.22～0.24 μ m filtering with microporous membrane; Lyophilization obtains sterilized powder, the packing embedding.
7. the preparation method of the described Chinese medicine preparation of claim 1 to 4, is characterized in that, the dosage form of described Chinese medicine preparation is tablet, and its preparation method comprises the following steps:
The first step: each raw medicinal material of described Chinese medicine preparation is mixed in proportion, adds the ethanol that the determining alcohol with respect to 5～8 times of mixture qualities is 75%～80%, reflux 4～6 hours, extract, and filters and obtain the first extracting solution; The medicinal residues that filter to obtain add the ethanol that the determining alcohol with respect to 3～5 times of medicinal residues quality is 70%～80% again, and reflux 120～180 minutes, extract, and filters and obtain the second extracting solution; The first extracting solution and the second extracting solution are merged, and concentrating under reduced pressure is removed alcohol solvent, and drying obtains and gets dry extract;
Second step: the dry cream that the first step is obtained is placed in super micron mill pulverizes 180～220 minutes, pulverizes and sieves and obtains 200～400 purpose micropowders;
The 3rd step: in the micropowders obtained at second step, add the microcrystalline Cellulose with respect to 0.25～0.45 times of its quality, the lactose of 0.25～0.4 times and the starch of 0.2～0.3 times, sieve, mix homogeneously, granulate, drying, add the magnesium stearate with respect to 0.03～0.05 times of micropowders quality, granulate, tabletting, make.
8. the preparation method of the described Chinese medicine preparation of claim 1 to 4, is characterized in that, the dosage form of described Chinese medicine preparation is injectable powder, and its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into the mixed powder that super micron mill is ground into the micron particles of 0.1～10 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 90%;
Second step, add the ethanol that the determining alcohol with respect to 4～6 times of the quality of described mixed powder is 90%～95% in the mixed powder that the first step obtains, stirring and dissolving obtains alcoholic solution, by alcoholic solution under the condition of 5 ℃～8 ℃ standing 50～80 hours, adopt percolation with the speed of 1～2ml per minute percolation slowly, collect percolate, concentrated and dry, and again put into super micron mill and pulverize 150～180 minutes, obtain the mixed powder of the micron particles of 0.1～10 μ m volume average particle size and the nano-scale particle composition that particle diameter is less than 0.1 μ m volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
The 3rd step, get mixed powder 100g～200g that second step obtains, and adds propylene glycol 350g～550g, add 4000ml water for injection, stir and make its dissolving, further inject water to 10000ml, add again 20g～40g needle-use activated carbon, fully stir 100～150 minutes; Decarbonization filtering; With 0.22～0.24 μ m filtering with microporous membrane; Lyophilization obtains sterilized powder, the packing embedding.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310349500.1A CN103417745B (en) | 2013-08-05 | 2013-08-05 | Chinese herbal preparation for treating acute cholecystitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310349500.1A CN103417745B (en) | 2013-08-05 | 2013-08-05 | Chinese herbal preparation for treating acute cholecystitis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103417745A true CN103417745A (en) | 2013-12-04 |
| CN103417745B CN103417745B (en) | 2015-04-22 |
Family
ID=49643485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310349500.1A Expired - Fee Related CN103417745B (en) | 2013-08-05 | 2013-08-05 | Chinese herbal preparation for treating acute cholecystitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103417745B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103599393A (en) * | 2013-12-11 | 2014-02-26 | 李慧静 | Traditional Chinese medicine for treating premature ovarian failure |
| CN104586998A (en) * | 2014-12-30 | 2015-05-06 | 冯清 | Traditional Chinese medicine preparation for treating cholecystitis, as well as preparation method thereof |
| CN104689295A (en) * | 2015-03-26 | 2015-06-10 | 尚乐 | Medicine for treating mycoplasma type colpitis |
| CN104758620A (en) * | 2015-04-22 | 2015-07-08 | 王玉玲 | Liver-soothing and bladder-relieving agent for patients with cholecystitis and preparation method of liver-soothing and bladder-relieving agent |
| CN104800567A (en) * | 2015-04-22 | 2015-07-29 | 王玉玲 | Traditional Chinese medicine preparation for treating cholecystitis and preparation method thereof |
| CN104984181A (en) * | 2015-07-14 | 2015-10-21 | 王彦刚 | Traditional Chinese medicine for treating toxic-heat internal stagnation type acute cholecystitis and preparing method of traditional Chinese medicine |
| CN105434733A (en) * | 2015-12-30 | 2016-03-30 | 吴嫱 | Traditional Chinese medicine for treating spleen-kidney yang deficiency thyroid nodules and preparation method for traditional Chinese medicine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102872359A (en) * | 2012-09-27 | 2013-01-16 | 孟宪兰 | Traditional Chinese medicine composition for treating chronic cholecystitis |
| CN102872261A (en) * | 2012-09-26 | 2013-01-16 | 济南星懿医药技术有限公司 | Application of straw berry tomato in preparing medicine for treating acute cholecystitis |
-
2013
- 2013-08-05 CN CN201310349500.1A patent/CN103417745B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102872261A (en) * | 2012-09-26 | 2013-01-16 | 济南星懿医药技术有限公司 | Application of straw berry tomato in preparing medicine for treating acute cholecystitis |
| CN102872359A (en) * | 2012-09-27 | 2013-01-16 | 孟宪兰 | Traditional Chinese medicine composition for treating chronic cholecystitis |
Non-Patent Citations (2)
| Title |
|---|
| 相兴樟: "中草药治疗胆囊炎二例", 《四川中医》, no. 3, 31 December 1985 (1985-12-31), pages 45 * |
| 谢兴亮等: "溪黄草的研究进展", 《医药导报》, vol. 30, no. 4, 30 April 2011 (2011-04-30), pages 494 - 497 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103599393A (en) * | 2013-12-11 | 2014-02-26 | 李慧静 | Traditional Chinese medicine for treating premature ovarian failure |
| CN104586998A (en) * | 2014-12-30 | 2015-05-06 | 冯清 | Traditional Chinese medicine preparation for treating cholecystitis, as well as preparation method thereof |
| CN104689295A (en) * | 2015-03-26 | 2015-06-10 | 尚乐 | Medicine for treating mycoplasma type colpitis |
| CN104758620A (en) * | 2015-04-22 | 2015-07-08 | 王玉玲 | Liver-soothing and bladder-relieving agent for patients with cholecystitis and preparation method of liver-soothing and bladder-relieving agent |
| CN104800567A (en) * | 2015-04-22 | 2015-07-29 | 王玉玲 | Traditional Chinese medicine preparation for treating cholecystitis and preparation method thereof |
| CN104984181A (en) * | 2015-07-14 | 2015-10-21 | 王彦刚 | Traditional Chinese medicine for treating toxic-heat internal stagnation type acute cholecystitis and preparing method of traditional Chinese medicine |
| CN105434733A (en) * | 2015-12-30 | 2016-03-30 | 吴嫱 | Traditional Chinese medicine for treating spleen-kidney yang deficiency thyroid nodules and preparation method for traditional Chinese medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103417745B (en) | 2015-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103417745B (en) | Chinese herbal preparation for treating acute cholecystitis and preparation method thereof | |
| CN103316219B (en) | One treats phthisical Chinese medicine preparation and preparation method thereof | |
| CN103393821B (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation and preparation method thereof | |
| CN103432243B (en) | Traditional Chinese medicinal preparation for treating infantile exudative otitis media and preparation method thereof | |
| CN104840695A (en) | Medicine combination for treating white scour of piglet and preparation method thereof | |
| CN104398980A (en) | Traditional Chinese medicine preparation for treating apoplectic hemiplegia and preparation method of traditional Chinese medicine preparation | |
| CN104042971A (en) | Medicine composition for treating yin deficiency toxic heat lung cancer and preparation method thereof | |
| CN103191331B (en) | Traditional Chinese medicine composition for treating bronchial asthma in remission stage | |
| CN101028490A (en) | Chinese medicine for treating acne | |
| CN104189289B (en) | A kind of Chinese medicine for the treatment of acute icterohepatitis and preparation method thereof | |
| CN103386101B (en) | Traditional Chinese medicine preparation for nonspecific cystitis treatment and preparation method thereof | |
| CN104998158A (en) | Pharmaceutical composition for treating liver cirrhosis and application thereof | |
| CN104547384A (en) | Oral liquid for treating paraquat poisoning and preparation method of oral liquid | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN118178589B (en) | A traditional Chinese medicine composition for treating gallstones and its application | |
| CN104800675A (en) | Medicament for treating active ulcerative colitis | |
| CN104800749A (en) | Medicine for treating diabetic nephropathy | |
| CN103386104B (en) | Traditional Chinese medicine composite for curing erysipelas and preparation method thereof | |
| CN103520637B (en) | Traditional Chinese medicine composition for treatment of dampness and heat accumulation type cholecystitis | |
| CN102423465A (en) | Chinese medicinal preparation for treating gallstone and preparation process thereof | |
| CN102293994A (en) | Medicine for treating thyroiditis and preparation method | |
| CN104645233A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
| CN105832823A (en) | Pharmaceutical preparation for treating preinvasive liver cancer and application of pharmaceutical preparation | |
| CN104586998A (en) | Traditional Chinese medicine preparation for treating cholecystitis, as well as preparation method thereof | |
| CN104587078A (en) | Traditional Chinese medicine preparation for treating viral pharyngitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 Termination date: 20160805 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |